Bisphenol S induces hepatic steatosis and insulin resistance through AMPK inhibition and endoplasmic reticulum stress
Food and Chemical Toxicology · 2026-09 · 215 · 116222
DOI: 10.1016/j.fct.2026.116222 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food and Chemical Toxicology, 2026-09. Verfasst von Vinicius Sepúlveda-Fragoso und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research Center on Morphology and Metabolism, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil; Laboratory of Experimental Endocr…. Hauptthemen laut MEDLINE: Phenols, Insulin Resistance, Endoplasmic Reticulum Stress, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: National Council for Scientific and Technological Development, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State.
Abstract (Originalsprache)
Bisphenol S (BPS), a common substitute for bisphenol A, has emerged as a widespread environmental contaminant, yet its metabolic effects remain poorly understood. Increasing evidence links BPS exposure to metabolic dysfunction-associated steatotic liver disease (MASLD), although the underlying mechanisms are unclear. Here, we investigated the metabolic effects of chronic BPS exposure (4, 25, and 50 μg/kg/day for 12 weeks) in C57BL/6 mice and evaluated its impact on human Huh-7 hepatocytes. In vivo, exposure to 25 μg/kg/day exhibited obesogenic potential, while all doses induced insulin resistance and promoted hepatic micro- and macrovesicular steatosis. BPS triggered endoplasmic reticulum (ER) stress and suppressed AMP-activated protein kinase (AMPK) phosphorylation, disrupting hepatic lipid and glucose metabolism. Consistently, BPS exposure in Huh-7 cells induced ER stress, reduced AMPK activity, and impaired insulin-stimulated Akt phosphorylation, indicating decreased insulin sensitivity. Notably, pharmacological activation of AMPK attenuated BPS-induced inhibition of insulin signaling, identifying AMPK as a key mediator of BPS-driven metabolic dysfunction in hepatocytes. Collectively, these findings demonstrate that BPS promotes hepatic steatosis and insulin resistance by activating ER stress and inhibiting AMPK, highlighting BPS as a potential environmental contributor to MASLD and related metabolic disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center on Morphology and Metabolism, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil; Laboratory of Experimental Endocrinology (LEEx), Institute of Biomedical Sciences, Federal University o…
- Research Center on Morphology and Metabolism, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil; Pathology Graduate Program, School of Medicine, Federal Fluminense University, Niteroi, Brazil; Nationa…
- Research Center on Morphology and Metabolism, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil; National Institute of Endocrine Disruptors and Endocrine-Metabolic Repercussions, Brazil.
- Pathology Graduate Program, School of Medicine, Federal Fluminense University, Niteroi, Brazil.
- Research Center on Morphology and Metabolism, Biomedical Institute, Fluminense Federal University, Niteroi, Brazil; Laboratory of Exercise Sciences, Federal Fluminense University, Niteroi, Brazil.
- Carlos Chagas Filho Institute of Biophysics, Federal University of Rio de Janeiro (UFRJ), Brazil; National Institute of Endocrine Disruptors and Endocrine-Metabolic Repercussions, Brazil.
Förderung
- National Council for Scientific and Technological Development
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
- Spain Ministry of Science Innovation and Universities
- Carlos III Health Institute
- European Regional Development Fund
- El Dorado Community Foundation
Zitieren
APA
Sepúlveda-Fragoso, V., Barreto-Reis, E., Carvalho-Laureano, T. S., Stockler-Pinto, M. B., Frantz, E. D. C., de Carvalho, D. P., Palomer, X., Barroso, E., Vázquez-Carrera, M., Miranda-Alves, L., & Magliano, D. C. (2026). Bisphenol S induces hepatic steatosis and insulin resistance through AMPK inhibition and endoplasmic reticulum stress. Food and Chemical Toxicology, 215, 116222. https://doi.org/10.1016/j.fct.2026.116222
Vancouver
Sepúlveda-Fragoso V, Barreto-Reis E, Carvalho-Laureano TS, Stockler-Pinto MB, Frantz EDC, de Carvalho DP, et al. Bisphenol S induces hepatic steatosis and insulin resistance through AMPK inhibition and endoplasmic reticulum stress. Food and Chemical Toxicology. 2026;215:116222. doi:10.1016/j.fct.2026.116222
BibTeX
@article{SeplvedaFragoso2026,
author = {Sepúlveda-Fragoso, Vinicius and Barreto-Reis, Emanuelle and Carvalho-Laureano, Thais de Souza and Stockler-Pinto, Milena Barcza and Frantz, Eliete Dalla Corte and de Carvalho, Denise Pires and Palomer, Xavier and Barroso, Emma and Vázquez-Carrera, Manuel and Miranda-Alves, Leandro and Magliano, D'Angelo Carlo},
title = {Bisphenol S induces hepatic steatosis and insulin resistance through AMPK inhibition and endoplasmic reticulum stress},
journal = {Food and Chemical Toxicology},
year = {2026},
volume = {215},
pages = {116222},
doi = {10.1016/j.fct.2026.116222}
}
EUVIMED